Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1908 clinical trials
featured
C1071003 MagnetisMM-3  

The purpose of the study is to evaluate whether single-agent PF-06863135 can provide clinical benefit in participants with relapsed/refractory multiple myeloma. PF-06863135 is a bispecific antibody: binding of PF-06863135 to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.

  • 0 views
  • 16 Apr, 2021
  • 3 locations
featured
CAHtalyst Study: A Research Study for Adults with Classic Congenital Adrenal Hyperplasia (CAH)

The CAHtalyst Study is a clinical research study evaluating an investigational medication for adults 18 years of age and older who have been diagnosed with classic congenital adrenal hyperplasia (CAH). The investigational medication is an oral capsule that will be taken twice daily with breakfast and evening meals. All participants who …

congenital adrenal hyperplasia
classic congenital adrenal hyperplasia
  • 30 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

This study will evaluate the safety, tolerability, and potential effects on cognition of GRF6021, a plasma-derived product, administered as an intravenous (IV) infusion, to subjects with Parkinson's disease and cognitive impairment.  

dementia
cognitive impairment
movement disorder
  • 42 views
  • 24 Jan, 2020
  • 1 location
featured
Is fatty liver disease hanging over your head?

If you have fatty liver, you may have some damage as well that is called nonalcoholic steatohepatitis (NASH). If you are interested in resources like lifestyle and weight management counseling, as well as a possible drug treatment the SYNERGY-NASH Study may be an option for you. Talk to your doctor …

  • 72 views
  • 23 Nov, 2020
  • 1 location
featured
Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

  • 1488 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

  • 588 views
  • 08 Nov, 2020
  • 1 location
featured
A Clinical Trial for Patients with Chronic Pancreatitis

A Clinical Trial for Patients with Chronic Pancreatitis

  • 1316 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

  • 1162 views
  • 25 Mar, 2021
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

  • 442 views
  • 25 Mar, 2021
  • 1 location
featured
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

  • 210 views
  • 23 Nov, 2020
  • 1 location